DMD and Duchenne muscular dystrophy: Thus, our work demonstrated that the nonmyeloablative transplantation of BMCs from syngeneic or allogeneic donors promotes dystrophin synthesis and improves the structures of SMFs and NMJs of muscle tissue in mdx mice; thus, it can be considered a promising approach for treating DMD.